New Delhi: In a major development, India and Brazil have secured the rights to buy enough quantities of COVID-19 vaccine to cover half the population of the respective nations as per data compiled by Duke Global Health Innovation Centre (DGHIC).
As per DGHIC, India has worked out deals with Pune-based Serum Institute of India (SII) and Novavax. Also, India is negotiating additional deals with some other companies. This gains significance as most of the richer nations have already purchased 3.8 billion doses of yet-to-be-produced and approved COVID-19 vaccines, while additional five billion doses are reserved or under negotiation.
